Victoria’s Secret posts longest sales growth streak in four years as shoppers return to Pink brand

Victoria’s Secret posts longest sales growth streak in four years as shoppers return to Pink brand


Victoria’s Secret store in New York.

Scott Mlyn | CNBC

Victoria’s Secret topped expectations during its holiday quarter and forecasted a better-than-expected year for sales growth on Thursday as CEO Hillary Super’s turnaround plan continues to resonate with shoppers.  

The legacy bra and underwear company beat Wall Street’s expectations on both the top and bottom lines and issued guidance that exceeded Wall Street’s expectations. 

For the current quarter, Victoria’s Secret is expecting sales to be between $1.49 billion and $1.53 billion, ahead of estimates of $1.42 billion. For the full year, it’s expecting that momentum to continue and anticipates sales will be between $6.85 billion and $6.95 billion, exceeding expectations of $6.8 billion. 

“In the quarter, our customer responded enthusiastically to our product and marketing, as demonstrated by growing new customer acquisition and increased [average until retails],” Super said in a statement. “Our 2025 results reflect the progress we have made against our Path to Potential strategy as we build brand heat and powerful connections with our customers around the world.”

Here’s how the retailer performed in its fiscal fourth quarter compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:

  • Earnings per share: $2.77 adjusted vs. $2.52 expected
  • Revenue: $2.27 billion vs. $2.23 billion expected

Despite the strong results and guidance, Victoria’s Secret shares dropped more than 6% in premarket trading Thursday.

The company’s net income for the three-month period that ended January 31 was $183.63 million, or $2.14 per share, compared with $193.4 million, or $2.33 per share, a year earlier. Excluding impairment charges related to its Adore Me assets, restructuring charges and other one-time expenses, Victoria’s Secret’s adjusted net income was $238 million, or $2.77 per share.

Sales rose to $2.27 billion, up about 8% from $2.11 billion a year earlier.

Pink brand clothes for sale at a Victoria’s Secret store on Fifth Avenue in New York, US, on Thursday, Sept. 4, 2025.

Gabby Jones | Bloomberg | Getty Images

Since taking over as Victoria’s Secret’s top executive about a year and a half ago, Super has worked to reignite sales growth and profitability by changing the way the company markets to shoppers, doubling down on its $1 billion beauty business, recommitting to its 2000s-era Pink line and reasserting its command of the bra category. A year later, the strategy is showing sustained signs of progress.

Comparable sales have grown for three quarters in a row now, including during its most recent quarter where comps spiked by 8%, better than the 5.6% uptick analysts had expected, according to StreetAccount. It’s the longest period of sustained comparable sales growth in at least four years, according to metrics from FactSet. 

Since it was spun off from its former parent company L Brands in 2021, Victoria’s Secret has until recently, tried unsuccessfully to regain its relevance with consumers. Its focus on ultra-sexy styles over comfortable and practical undergarments, paired with out of touch marketing, pushed shoppers to emerging disruptors and other legacy competitors, leading to a decline in market share. 

It acquired digital upstart Adore Me in 2022 as a way to meet a wider range of shoppers and body types through the brand’s focus on inclusive sizing and a range of lingerie styles that span from sexy to comfortable. But the acquisition wasn’t enough to get Victoria’s Secret back to sustained growth. 

During the quarter, the company took $119.6 million in impairment charges related to Adore Me and also said it was initiating a “strategic review” of DailyLook, a brand acquired through the Adore Me transaction. Strategic reviews often include finding a buyer willing to acquire the brand.



Source

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
Business

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications. Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at pharmacies and on […]

Read More
Apartment rents weaken further as war and job cuts weigh on demand
Business

Apartment rents weaken further as war and job cuts weigh on demand

Key Points March rents were down 1.7% on an annual basis, according to Apartment List. That’s the largest drop since Apartment List began tracking in 2017and larger than the record set in the early months of the Covid pandemic. Rents are falling because vacancies are also unusually high. A version of this article first appeared […]

Read More
Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers
Business

Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers

In 1984, Volkswagen partnered with a Chinese automaker because it was required by Chinese law. Now the German company is partnering with Chinese automakers because it wants to use their technology. Volkswagen Group today maintains the original joint ventures it made with Chinese automakers in those early days of its foray into what has become […]

Read More